Literature DB >> 15628761

[Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].

Shinji Otani1, Nobuhiko Toyota, Kimiyasu Nozaka, Toshiro Wakatsuki, Masataka Takebayashi, Akira Kamasako, Osamu Tanida, Hirokazu Hashiguchi, Yoshimi Ohgami, Yasuaki Hirooka.   

Abstract

We report a case of breast cancer with spinal and vertebral lesions. A 49-year-old premenopausal woman with a left breast tumor was admitted to our hospital for acute weakness of the lower limbs and dysuria. She could neither stand nor walk. The tumor in the left breast was 5.0 cm in diameter with skin ulcer, and it was diagnosed as breast cancer. Magnetic resonance (MR) image showed multiple vertebral and spinal metastases from breast cancer. Chemotherapy, consisting of cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) was initiated. Her symptoms dramatically changed for the better. She became able to walk and urinate. We performed palliative mastectomy after 3 cycles of CAF therapy. Histopathological findings of breast tumor showed scirrhous carcinoma. Although the estrogen and progesterone receptor status of primary tumor was negative, chemo-endocrine therapy, consisting of medroxyprogesterone acetate (MPA) and doxifluridine (5'-DFUR) was given as daily therapy, and vertebral and spinal lesions were reduced. Her condition has remained stable for 4 years. For patients with metastatic breast cancer, complete remission is uncommon, and disease stabilization is a reasonable goal of successful therapy. In this respect, therapy with CAF, followed by MPA and 5'-DFUR, was successful in the patient.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15628761

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.

Authors:  Donata Micello; Alessandro Marando; Nora Sahnane; Cristina Riva; Carlo Capella; Fausto Sessa
Journal:  Virchows Arch       Date:  2010-08-31       Impact factor: 4.064

2.  Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells.

Authors:  Mingxuan Xie; Li Zhou; Xi Chen; Lindsey O Gainey; Jian Xiao; Mark S Nanes; Anji Hou; Shaojin You; Qiong Chen
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.